What is Edvotek?
Edvotek serves as a pioneer and market leader in the development of biotechnology experiments and laboratory equipment tailored for educational environments. The company provides a comprehensive suite of tools, including electrophoresis units, thermal cyclers, and precision pipetting systems, designed to facilitate reproducible scientific results in classrooms. By offering custom LabStation configurations, Edvotek addresses the diverse budgetary and technical requirements of educators, effectively bridging the gap between complex biotechnology research and accessible STEM learning. Their focus on high-quality, durable equipment, backed by lifetime warranties, has established the firm as an essential partner for institutions aiming to modernize their science curricula.
How much funding has Edvotek raised?
Edvotek has raised a total of $774K across 2 funding rounds:
Debt
$350K
Debt
$424K
Debt (2020): $350K with participation from PPP
Debt (2021): $424K led by PPP
Key Investors in Edvotek
PPP
Public-Private Partnership
What's next for Edvotek?
The recent influx of capital positions Edvotek to accelerate its product development roadmap and enhance its service offerings for the evolving educational landscape. As the demand for advanced biotechnology training grows, the company is well-positioned to leverage its established reputation to capture additional market share. Strategic priorities likely include the expansion of its digital and physical laboratory ecosystem, ensuring that teachers are equipped with the latest tools to foster the next generation of scientists. By maintaining its focus on pedagogical excellence and technical reliability, Edvotek is poised to lead the transformation of science education, ensuring that its offerings remain at the forefront of the industry's technological advancements.
See full Edvotek company page
